cGxP.wire https://validator.w3.org/feed/docs/rss2.html Cellectis Secures FDA RMAT Status for Lasme-cel Penumbra Gains FDA Approval for THUNDERBOLT Thrombectomy System ZYUS Life Sciences Realigns Operations to Advance Non-Opioid Drug Pipeline Oncolys BioPharma Secures Japan Approval for Telomelysin in Esophageal Cancer Roche Expands VENTANA MMR Companion Diagnostic Across Multiple Cancer Types Xeris Pharmaceuticals Receives USPTO Patent Allowance for KEVEYIS Airiver Treats First Patient in Pivotal CRS Balloon Trial FDA Approves New Sunscreen Ingredient After Two Decades Roche’s Tecentriq Receives FDA Priority Review for Stage III Colon Cancer DKSH and BridgeBio Partner to Expand ATTR-CM Treatment Access Elixiron Reports Positive Phase 2 Enrupatinib Data in Alzheimer’s Disease Takeda’s Zasocitinib Outperforms Deucravacitinib in Psoriasis HERVolution Advances Immune Therapy for Metabolic Disease Johnson & Johnson’s IMAAVY Delivers Breakthrough Results in wAIHA Formosa Pharma Expands APP13007 Reach Through Samil Deal Caliway Presents CBL-514 Data Showing Reduced Weight Regain with GLP-1 Therapies Enliven Therapeutics Reports Positive ELVN-001 Phase 1 Data Anixa Biosciences Highlights Clinical Immunotherapy Progress at Cancer Symposium Novartis and Orionis Expand AI-Powered Molecular Glue Alliance Certified Group Achieves FDA Acceptance for Seafood PFAS Analysis Evaxion Presents New Preclinical Data for EVX-04 in Acute Myeloid Leukemia BioInvent’s TNFR2 Antibody BI-1808 Shows Promising Responses in Advanced CTCL at EHA 2026 Cellectis Presents Final Phase 1 Results of Lasme-cel and Preliminary Eti-cel Data at EHA 2026 Anocca Doses First Patients with KRAS-Targeted TCR-T Therapy Vertex Reports Successful Phase 3 CASGEVY Outcomes in Pediatrics Teva Acquires Emalex to Advance Tourette Syndrome Therapy Matter Bio Wins FDA IND Clearance for LM-LLO-TT Trial SpinaFX Wins FDA IDE for Triojection Lumbar Disc Therapy Sonex Health Reports Largest U.S. Study Supporting UltraGuideCTR for Carpal Tunnel Subtle Medical Secures FDA Clearance for AI-Powered SubtleHD CT Takeda’s ENTYVIO Nears Pediatric IBD FDA Approval Philips Finds AI Boosting Patient Access and Clinical Efficiency Worldwide Smith+Nephew Launches Next-Generation CORI XT Robotics Nasus Pharma Reports Positive Preclinical Results for NS003 Imviva Biotech Advances CTA313 CAR-T Program with FDA IND Approval Disc Medicine Shares FDA Meeting Outcomes for Bitopertin Eli Lilly and Shaquille O’Neal Raise Awareness of Treatable Sleep Apnea with Zepbound Matica Biotechnology Partners with UHN on IL-10 Gene Therapy Manufacturing Vara Secures CE Mark for 3D Mammography AI Platform UCB Receives Favorable Canadian Reimbursement Opinion for BIMZELX Lilly’s EBGLYSS Wins FDA Approval for Reduced Injection Schedule Formation Bio Doses First Participant in Phase 1 Trial of BLKR201, a CNS-Penetrant TYK2 Inhibitor Kyowa Kirin Highlights Vision 2030 in Integrated Report Syntax Bio Teams Up with Mayo Clinic to Advance Diabetes Treatment Onkos Surgical Receives FDA Nod for NanoCept-Enhanced Implants Alpha Cognition Reports Positive BEACON Study Results for ZUNVEYL Zetagen Therapeutics Reports Positive Phase 2a ZetaMet Results Multi Radiance Medical Expands FDA-Cleared Laser Therapy Indications Curium Completes Phase 2 Dosing for 64Cu-PSMA-I&T in Japan Novartis Del-Brax Shows Breakthrough Potential in FSHD